

Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections.
| Headquarter | 675 Massachusetts Avenue, 14th Floor Cambridge, MA United States of America |
|---|---|
| Website | sperotherapeutics.com/ |
| Founding Date | 2013 |
| Company Status | Public |
| Stock | SPRO |
Spero Therapeutics competitors include Pear Therapeutics and Tactile Systems Technology. Spero Therapeutics ranks 2nd in Overall Culture Score on Comparably vs its competitors. See below how Spero Therapeutics compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
2 employees at Spero Therapeutics have reviewed Spero Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from employees about joining Spero Therapeutics is that the company was very prepared on their first day. Spero Therapeutics employees concluded that their overall onboarding experience was positive. 100% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
Employees’ understanding of Spero Therapeutics' KPIs and OKRs is essential for its success. Out of 1 Spero Therapeutics employees who’ve answered, “Are your company’s goals clear and are you invested in them?” 1 have said yes.

Ankit Mahadevia CEO / President
Ankit Mahadevia serves as the CEO / President of Spero Therapeutics.

Cristina Larkin Chief Operating Officer
Ms. Cristina Larkin has been Chief Operating Officer of Spero Therapeutics, LLC and Spero Therapeutics, Inc. since...

Joel D. Sendek CFO & Principal Accounting Officer
Mr. Joel D. Sendek has been the Chief Financial Officer of Spero Therapeutics, Inc. since May 22, 2017 and serves as its...

Thomas R. Parr Jr., Ph.D. Chief Scientific Officer
Dr. Thomas R. Parr, Jr., also known as Tom, Ph.D., has been Chief Scientific Officer at Spero Therapeutics, Inc. since...

Tim Keutzer Senior Vice President
Tim Keutzer serves as the Senior Vice President of Spero Therapeutics. Tim started at Spero Therapeutics in Aug of 2015....

Ian Critchley Vice President, Head of Clinical Microbiology
Ian Critchley serves as the Vice President, Head of Clinical Microbiology of Spero Therapeutics. Ian started at Spero...

Stephen Garbacz SVP Finance and Operations
Stephen Garbacz serves as the SVP Finance and Operations of Spero Therapeutics. Stephen started at Spero Therapeutics in...

Troy Lister Vice President Research
Troy Lister serves as the Vice President Research of Spero Therapeutics. Troy started at Spero Therapeutics in September...

David Melnick Chief Medical Officer
David Melnick serves as the Chief Medical Officer of Spero Therapeutics. David started at Spero Therapeutics in January...
Leading members of the Spero Therapeutics Human Resources Team include Jay Blackington.

Jay Blackington VP, Head of People and Culture
Jay Blackington serves as the VP, Head of People and Culture of Spero Therapeutics. Jay started at Spero Therapeutics in...

No Recent Jobs found for Spero Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

Candidates By Department
All Industries | 100% |
|---|
Candidates By Location
Boston | 100% |
|---|
What is Spero Therapeutics address?
Spero Therapeutics location is at 675 Massachusetts Avenue, 14th Floor
Who is the CEO of Spero Therapeutics?
Spero Therapeutics CEO is Ankit Mahadevia, their score by employees is 80
What is Spero Therapeutics revenue?
Spero Therapeutics revenue is $2M
Who are Spero Therapeutics competitors?
Spero Therapeutics main competitors are Pear Therapeutics, Tactile Systems Technology
Who is Spero Therapeutics leadership?
Cristina Larkin, Joel D. Sendek, Thomas R. Parr Jr. & Ph.d. are part of Spero Therapeutics leadership, Ankit Mahadevia is the CEO